Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-24-072891

Options or other derivatives

  • Chief Operating Officer acquired 500,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Longcor Jarrod Chief Operating Officer 2024-06-14 Grant or award · Stock option (right to buy) +500,000 500,000 D
Loading xslF345X05/tm2417520-10_4seq1.xml…